LL-37
$90.00
Overview
Research-use cationic cathelicidin peptide supplied for studies of innate immune signaling, host-defense pathways, and epithelial response models.
- Concentration
- 5 mg
- Stock
- In stock
Material profile
LL-37 is a synthetic cationic cathelicidin peptide derived from hCAP18 and used in innate immune and epithelial signaling research models. Pattern lists this material for controlled laboratory research.
- Research Targets
- Microbial membrane interaction models, TLR signaling, chemotaxis pathways, epithelial immune signaling.
- Key Feature
- Human cathelicidin-derived peptide format for host-defense pathway research.
- Research Focus Areas
- Innate immune response models, epithelial barrier signaling, inflammatory pathway studies, wound-response models.
- Common Models
- Microbial membrane assays, epithelial and keratinocyte cell models, cytokine response assays.
- Mechanistic Interests
- Membrane interaction, TLR pathway markers, chemokine signaling, immunomodulatory response markers.
- Use Boundary
- Research use only; not for human or veterinary use; no diagnostic, therapeutic, or consumption use is implied.
